Literature DB >> 29356980

Vanillic acid attenuates cerebral hyperemia, blood-brain barrier disruption and anxiety-like behaviors in rats following transient bilateral common carotid occlusion and reperfusion.

Seyed Esmaeil Khoshnam1, Yaghoob Farbood2, Hadi Fathi Moghaddam3, Alireza Sarkaki3, Mohammad Badavi3, Layasadat Khorsandi4.   

Abstract

Transient bilateral common carotid artery occlusion (tBCCAO), followed by reperfusion, is a model of transient global hypoperfusion. In the present study we aimed to investigate the probable effects of Vanillic acid (VA) on some physiological parameters including cerebral hyperemia, blood-brain barrier (BBB) disruption, anxiety behaviors and neurological deficits induced by bilateral occlusion of the common carotid arteries and reperfusion (BCCAO/R) in rats. Rats were randomly divided into four groups; Sham, BCCAO/R, VA and VA+ BCCAO/R. Chronic cerebral hypoperfusion was induced after 2 weeks of pretreatment by VA. Subsequently, sensorimotor scores, elevated plus maze tests, cerebral hyperemia, and BBB disruption were evaluated 72 h after 30 min of BCCAO. Pretreatment of rats by VA improved sensory motor signs, anxiolytic behavior in BCCAO/R rats compared with untreated rats (p < 0.05). Further, VA attenuated reactive hyperemia and BBB disruption in BCCAO/R rats compared with untreated rats (p < 0.01). To our knowledge, this study is the first to reveal VA could attenuate reactive hyperemia and improve BBB disruption following BCCAO/R, and could improve neurological scores and anxiety like behaviors in this model of cerebral hypoperfusion. These results suggest that VA could be a promising pretreatment agent in cerebral hypoperfusion.

Entities:  

Keywords:  Anxiety; Bilateral common carotid artery occlusion; Blood-brain barrier; Hgyperemia; Reperfusion; Vanillic acid

Mesh:

Substances:

Year:  2018        PMID: 29356980     DOI: 10.1007/s11011-018-0187-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  60 in total

Review 1.  The protective effects of natural products on blood-brain barrier breakdown.

Authors:  A Kam; K M Li; V Razmovski-Naumovski; S Nammi; K Chan; Y Li; G Q Li
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats.

Authors:  Chin-Yi Cheng; Shan-Yu Su; Nou-Ying Tang; Tin-Yun Ho; Su-Yin Chiang; Ching-Liang Hsieh
Journal:  Brain Res       Date:  2008-03-18       Impact factor: 3.252

3.  Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats.

Authors:  Christine A O'Connor; Ibolja Cernak; Robert Vink
Journal:  Brain Res       Date:  2005-10-26       Impact factor: 3.252

4.  Anxious and hyperactive phenotype following brief ischemic episodes in mice.

Authors:  Benjamin Winter; Georg Juckel; Ilya Viktorov; Juri Katchanov; Andrea Gietz; Reinhard Sohr; Mustafa Balkaya; Heide Hörtnagl; Matthias Endres
Journal:  Biol Psychiatry       Date:  2005-05-15       Impact factor: 13.382

5.  Protection against blood-brain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: a quantitative study.

Authors:  L Belayev; R Busto; M Ikeda; L L Rubin; A Kajiwara; L Morgan; M D Ginsberg
Journal:  Brain Res       Date:  1998-03-23       Impact factor: 3.252

6.  Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats.

Authors:  Fernando J Pérez-Asensio; Xavier de la Rosa; Francesc Jiménez-Altayó; Roser Gorina; Emili Martínez; Angel Messeguer; Elisabet Vila; Angel Chamorro; Anna M Planas
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

7.  Early blood-brain barrier disruption in human focal brain ischemia.

Authors:  Lawrence L Latour; Dong-Wha Kang; Mustapha A Ezzeddine; Julio A Chalela; Steven Warach
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

8.  Laser-Doppler scanning of local cerebral blood flow and reserve capacity and testing of motor and memory functions in a chronic 2-vessel occlusion model in rats.

Authors:  P T Ulrich; S Kroppenstedt; A Heimann; O Kempski
Journal:  Stroke       Date:  1998-11       Impact factor: 7.914

Review 9.  General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage.

Authors:  Heng Zhao; Gary K Steinberg; Robert M Sapolsky
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-08       Impact factor: 6.200

10.  Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion.

Authors:  Yanqun Liu; Guanghui Tang; Yaning Li; Yang Wang; Xiaoyan Chen; Xiang Gu; Zhijun Zhang; Yongting Wang; Guo-Yuan Yang
Journal:  J Neuroinflammation       Date:  2014-10-15       Impact factor: 8.322

View more
  13 in total

Review 1.  The role of non-coding RNAs in neuroprotection and angiogenesis following ischemic stroke.

Authors:  Elaheh Heydari; Masoumeh Alishahi; Farhoodeh Ghaedrahmati; William Winlow; Seyed Esmaeil Khoshnam; Amir Anbiyaiee
Journal:  Metab Brain Dis       Date:  2019-08-24       Impact factor: 3.584

2.  Ellagic acid attenuates post-cerebral ischemia and reperfusion behavioral deficits by decreasing brain tissue inflammation in rats.

Authors:  Khadijeh Hassonizadeh Falahieh; Alireza Sarkaki; Mohammadamin Edalatmanesh; Mohammad Kazem Gharib Naseri; Yaghoob Farbood
Journal:  Iran J Basic Med Sci       Date:  2020-05       Impact factor: 2.699

Review 3.  Long non-coding RNAs and cell death following ischemic stroke.

Authors:  Masoumeh Alishahi; Farhoodeh Ghaedrahmati; Tannaz Akbari Kolagar; William Winlow; Negin Nikkar; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Metab Brain Dis       Date:  2019-05-04       Impact factor: 3.584

4.  Hypertension, Anxiety, and Blood-Brain Barrier Permeability Are Increased in Postpartum Severe Preeclampsia/Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome Rats.

Authors:  Kedra Wallace; Cynthia Bean; Teylor Bowles; Shauna-Kay Spencer; Wisdom Randle; Patrick B Kyle; James Shaffery
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 5.  Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health.

Authors:  Kirsten Berding; Klara Vlckova; Wolfgang Marx; Harriet Schellekens; Catherine Stanton; Gerard Clarke; Felice Jacka; Timothy G Dinan; John F Cryan
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

Review 6.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 7.  Anthocyanins and Their Metabolites as Therapeutic Agents for Neurodegenerative Disease.

Authors:  Aimee N Winter; Paula C Bickford
Journal:  Antioxidants (Basel)       Date:  2019-08-22

Review 8.  Mesenchymal Stem Cell-Mediated Mitochondrial Transfer: a Therapeutic Approach for Ischemic Stroke.

Authors:  Meng Lu; Jindong Guo; Bowen Wu; Yuhui Zhou; Mishan Wu; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Transl Stroke Res       Date:  2020-09-25       Impact factor: 6.829

Review 9.  Therapeutic Effects of Resveratrol on Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Alireza Sarkaki; Mojtaba Rashidi; Mina Ranjbaran; Aram Asareh Zadegan Dezfuli; Zahra Shabaninejad; Ebrahim Behzad; Maryam Adelipour
Journal:  Neurochem Res       Date:  2021-08-07       Impact factor: 3.996

10.  Resveratrol Regulates BDNF, trkB, PSA-NCAM, and Arc Expression in the Rat Cerebral Cortex after Bilateral Common Carotid Artery Occlusion and Reperfusion.

Authors:  Maria Pina Serra; Marianna Boi; Laura Poddighe; Tiziana Melis; Ylenia Lai; Gianfranca Carta; Marina Quartu
Journal:  Nutrients       Date:  2019-05-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.